Cubist Systematic Strategies’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1560 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1488 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1530 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1509 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1516 |
|
|
2024
Q1 | – | Sell |
-11,511
| Closed | -$465K | – | 2234 |
|
|
2023
Q4 | $465K | Buy |
+11,511
| New | +$465K | ﹤0.01% | 1377 |
|
|
2023
Q3 | – | Sell |
-185,063
| Closed | -$3.18M | – | 2001 |
|
|
2023
Q2 | $3.18M | Sell |
185,063
-33,583
| -15% | -$578K | 0.02% | 673 |
|
|
2023
Q1 | $3.63M | Buy |
218,646
+211,721
| +3,057% | +$3.51M | 0.02% | 784 |
|
|
2022
Q4 | $52.8K | Sell |
6,925
-452,011
| -98% | -$3.44M | ﹤0.01% | 2937 |
|
|
2022
Q3 | $4.56M | Buy |
458,936
+217,940
| +90% | +$2.17M | 0.03% | 901 |
|
|
2022
Q2 | $2.19M | Sell |
240,996
-5,735
| -2% | -$52.1K | 0.01% | 1498 |
|
|
2022
Q1 | $2.5M | Buy |
246,731
+183,439
| +290% | +$1.86M | 0.02% | 1297 |
|
|
2021
Q4 | $1.06M | Buy |
63,292
+51,656
| +444% | +$862K | 0.01% | 1871 |
|
|
2021
Q3 | $545K | Buy |
+11,636
| New | +$545K | 0.01% | 1977 |
|
|
2021
Q2 | – | Sell |
-3,738
| Closed | -$230K | – | 2919 |
|
|
2021
Q1 | $230K | Sell |
3,738
-4,188
| -53% | -$258K | ﹤0.01% | 2392 |
|
|
2020
Q4 | $564K | Sell |
7,926
-20,875
| -72% | -$1.49M | 0.01% | 1705 |
|
|
2020
Q3 | $1.08M | Buy |
+28,801
| New | +$1.08M | 0.02% | 1285 |
|